Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
General Pulmonary
What tidal volume or minute ventilation goals do you target when titrating NIPPV in a patient with COPD exacerbation with hypercapnia?
Do the findings of the
HAPPEN
trial influence your approach?
Related Questions
When interpreting pulmonary function tests (PFTs), do you include diagnostic language such as 'findings are suggestive of COPD,' or do you limit your report to a descriptive interpretation of the data?
When interpreting pulmonary function tests, do you routinely distinguish between hyperinflation and gas trapping?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What is your next step in treatment for tobacco use disorder for a patient who continues to smoke after 12 weeks of therapy with varenicline?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
Does rituximab have a potential role in the management of immune checkpoint inhibitor induced pneumonitis?
How do you manage PEEP in a morbidly patient with severe hypoxia who is already proned with no access to esophageal ballon?
Is it clinically necessary to provide supplemental oxygen to patients with mild, asymptomatic hypoxemia only during activity while they are recovering from an acute respiratory illness?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
Is the recommended duration of anticoagulation different for provoked DVT compared to provoked PE?